[1] |
ZHAO R H, SUN W W, LIU Y, et al. Chinese medicine in management of chronic disease endometriosis[J]. Chin J Integr Med,2020,26(2):88-91. doi: 10.1007/s11655-018-2937-3 |
[2] |
邢心睿, 吕狄亚, 柴逸峰, 等. 网络药理学在中药作用机制中的研究进展[J]. 药学实践杂志, 2018, 36(2):97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001 |
[3] |
LUO T T, LU Y, YAN S K, et al. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective[J]. Chin J Integr Med,2020,26(1):72-80. doi: 10.1007/s11655-019-3064-0 |
[4] |
RU J L, LI P, WANG J N, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform,2014,6:13. doi: 10.1186/1758-2946-6-13 |
[5] |
薛潇春, 胡晋红. 网络药理学的研究方法与应用进展[J]. 药学实践杂志, 2015, 33(5):401-405. doi: 10.3969/j.issn.1006-0111.2015.05.005 |
[6] |
MA C T, JIANG Y X, ZHANG X H, et al. Isoquercetin ameliorates myocardial infarction through anti-inflammation and anti-apoptosis factor and regulating TLR4-NF-κB signal pathway[J]. Mol Med Rep,2018,17(5):6675-6680. |
[7] |
VAN DER WOUDE H, TER VELD M G, JACOBS N, et al. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor[J]. Mol Nutr Food Res,2005,49(8):763-771. doi: 10.1002/mnfr.200500036 |
[8] |
李星霞, 郭澄. 木犀草素的药理活性研究[J]. 中国药房, 2007, 18(18):1421-1424. doi: 10.3969/j.issn.1001-0408.2007.18.029 |
[9] |
王继双, 何焱, 张文静, 等. 木犀草素的药理作用研究进展[J]. 生命科学, 2013, 25(6):560-565. |
[10] |
张雅雯, 邵东燕, 师俊玲, 等. 山奈酚生物功能研究进展[J]. 生命科学, 2017, 29(4):400-405. |
[11] |
LAI Z Z, YANG H L, HA S Y, et al. Cyclooxygenase-2 in endometriosis[J]. Int J Biol Sci,2019,15(13):2783-2797. doi: 10.7150/ijbs.35128 |
[12] |
吴亚玲, 郝敏. 趋化因子在子宫内膜异位症发病机制中的作用[J]. 国际妇产科学杂志, 2009, 36(5):352-355. doi: 10.3969/j.issn.1674-1870.2009.05.004 |
[13] |
KUMAGAMI A, ITO A, YOSHIDA-KOMIYA H, et al. Expression patterns of the steroid receptor coactivator family in human ovarian endometriosis[J]. J Obstet Gynaecol Res,2011,37(10):1269-1276. doi: 10.1111/j.1447-0756.2010.01509.x |
[14] |
SHI X, XU W, DAI H H, et al. The role of SRC1 and SRC2 in steroid-induced SDF1 expression in normal and ectopic endometrium[J]. Reproduction,2014,147(6):847-853. doi: 10.1530/REP-14-0027 |
[15] |
倪喆鑫, 张丹英, 姚睿嫔, 等. 活化血小板在子宫内膜异位症病理过程中的作用及抗血小板相关药物的治疗[J]. 生殖医学杂志, 2018, 27(12):1250-1254. doi: 10.3969/j.issn.1004-3845.2018.12.018 |
[16] |
GUO S W, DU Y B, LIU X S. Endometriosis-derived stromal cells secrete thrombin and thromboxane A2, inducing platelet activation[J]. Reprod Sci,2016,23(8):1044-1052. doi: 10.1177/1933719116630428 |
[17] |
陈晓莉, 焦桂青. Ang-2、VEGF在子宫内膜异位症中的表达[J]. 海南医学院学报, 2016, 22(2):166-168. |
[18] |
尉伟东, 阮菲, 涂飞霞, 等. 细胞因子信号传送阻抑物-3和caspase-3在子宫内膜异位症中的表达及其相关性[J]. 中华病理学杂志, 2013, 42(8):515-518. doi: 10.3760/cma.j.issn.0529-5807.2013.08.003 |
[19] |
MADANES D, BILOTAS M A, BASTÓN J I, et al. PI3K/AKT pathway is altered in the endometriosis patient's endometrium and presents differences according to severity stage[J]. Gynecol Endocrinol,2020,36(5):436-440. doi: 10.1080/09513590.2019.1680627 |
[20] |
JIANG L, YAN Y, LIU Z, et al. Inflammation and endometrio- sis[J]. Front Biosci,2016,21(5):941-948. doi: 10.2741/4431 |
[21] |
许丽华. EMAb、CA125、TNF-α与子宫内膜异位症的相关性[J]. 中国妇幼保健, 2011, 26(28):4336-4338. |
[22] |
任伟俏, 孙高高, 李晶, 等. 子宫内膜异位症患者血清CD38、缩宫素、白介素-1β表达情况及相关性研究[J]. 中国妇幼保健, 2019, 34(7):1660-1663. |
[23] |
SIKORA J, MIELCZAREK-PALACZ A, KONDERA-ANASZ Z. Association of the precursor of interleukin-1β and peritoneal inflammation-role in pathogenesis of endometriosis[J]. J Clin Lab Anal,2016,30(6):831-837. doi: 10.1002/jcla.21944 |
[24] |
SIKORA J, FERRERO S, MIELCZAREK-PALACZ A, et al. The delicate balance between the good and the bad IL-1 proinflammatory effects in endometriosis[J]. Curr Med Chem,2018,25(18):2105-2121. doi: 10.2174/0929867325666180111093547 |
[25] |
TANIGUCHI F, KAPONIS A, IZAWA M, et al. Apoptosis and endometriosis[J]. Front Biosci,2011,E3(2):648-662. doi: 10.2741/e277 |
[26] |
YU C Q, YU J, HAN J, et al. Regulatory mechanism of malignant behavior of endometriosis mediated by puerarin[J]. J Chin Integr Med,2009,7(1):41-47. doi: 10.3736/jcim20090106 |
[27] |
CHO S, CHOI Y S, JEON Y E, et al. Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 in endometriosis[J]. Microvasc Res,2012,83(2):237-242. doi: 10.1016/j.mvr.2011.12.004 |
[28] |
DING S J, ZHU T H, TIAN Y H, et al. Role of brain-derived neurotrophic factor in endometriosis pain[J]. Reprod Sci,2018,25(7):1045-1057. doi: 10.1177/1933719117732161 |